These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 2292916

  • 21. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group.
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [Abstract] [Full Text] [Related]

  • 22. [Effectiveness and tolerability of simvastatin in subjects with primary hypercholesterolemia. Multicenter study].
    Finardi G, Perani G, Tramarin R, Ricciardi R, Falaschi F, Franco C.
    Clin Ter; 1993 Mar; 142(3):225-33. PubMed ID: 8482062
    [Abstract] [Full Text] [Related]

  • 23. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, Kim HS, Park SH, Seo HS, Shin DG, Shin YW, Shim WJ, Ahn TH, Ho Yun K, Yoon MH, Cha KS, Choi SW, Han SW, Hyon MS.
    Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia.
    Krempf M, Rohmer V, Farnier M, Issa-Sayegh M, Corda C, Sirugue I, Gerlinger C, Masseyeff-Elbaz MF.
    Diabetes Metab; 2000 May; 26(3):184-91. PubMed ID: 10880891
    [Abstract] [Full Text] [Related]

  • 25. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K, Sasaki J, Arakawa K.
    Clin Ther; 1989 May; 11(2):247-57. PubMed ID: 2736571
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T, Davidson M, Shah A, Maccubbin D, Meehan A, Zakson M, Tribble D, Veltri E, Mitchel Y.
    Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
    [Abstract] [Full Text] [Related]

  • 27. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E, Ezetimibe Study Group.
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [Abstract] [Full Text] [Related]

  • 28. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR, Crouse JR, Hunninghake DB, Davidson MH, Escobar ID, Stalenhoef AF, Paragh G, Ma PT, Liu M, Melino MR, O'Grady L, Mercuri M, Mitchel YB, Simvastatin Atorvastatin HDL Study Group.
    Curr Med Res Opin; 2001 Dec; 17(1):43-50. PubMed ID: 11464446
    [Abstract] [Full Text] [Related]

  • 29. [Lovastatin. A new drug for the treatment of hypercholesterolemia].
    Abouganem D, Núñez P.
    Rev Med Panama; 1990 Sep; 15(3):184-96. PubMed ID: 2284448
    [Abstract] [Full Text] [Related]

  • 30. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
    Crespo N, Illnait J, Más R, Fernández L, Fernández J, Castaño G.
    Int J Clin Pharmacol Res; 1999 Sep; 19(4):117-27. PubMed ID: 10939029
    [Abstract] [Full Text] [Related]

  • 31. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.
    Reyna-Villasmil N, Bermúdez-Pirela V, Mengual-Moreno E, Arias N, Cano-Ponce C, Leal-Gonzalez E, Souki A, Inglett GE, Israili ZH, Hernández-Hernández R, Valasco M, Arraiz N.
    Am J Ther; 2007 Sep; 14(2):203-12. PubMed ID: 17414591
    [Abstract] [Full Text] [Related]

  • 32. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR, Ezetimibe Study Group.
    Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688
    [Abstract] [Full Text] [Related]

  • 33. [Treatment of severe primary hypercholesterolemia with lovastatin (Mevacor). A new therapeutic principle].
    Leth A, Munch M, Nielsen B, Dollerup J.
    Ugeskr Laeger; 1990 Nov 05; 152(45):3354-7. PubMed ID: 2238228
    [Abstract] [Full Text] [Related]

  • 34. Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemia.
    Bradford RH, Shear CL, Chremos AN, Dujovne C, Franklin FA, Hesney M, Higgins J, Langendörfer A, Pool JL, Schnaper H.
    Am J Cardiol; 1990 Sep 18; 66(8):44B-55B. PubMed ID: 2206036
    [Abstract] [Full Text] [Related]

  • 35. A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia.
    D'Agostino RB, Kannel WB, Stepanians MN, D'Agostino LC.
    Am J Cardiol; 1992 Jan 01; 69(1):28-34. PubMed ID: 1729864
    [Abstract] [Full Text] [Related]

  • 36. [The effect of lovastatin in the treatment of primary hypercholesterolemia].
    Chi JM, Li LS, Sun MZ.
    Zhonghua Nei Ke Za Zhi; 1992 Jan 01; 31(1):32-4, 61. PubMed ID: 1395911
    [Abstract] [Full Text] [Related]

  • 37. [An evaluation of the hypolipidemic effects of lovastatin in primary hypercholesterolemia. A multicenter study].
    Liakishev AA, Kukharchuk VV, Titov VN, Volkova EI, Konstantinov VO, Lipovetskiĭ BM, Soliternova IB, Dudko VA, Kanskaia NV, Kryzhanovskiĭ VA.
    Kardiologiia; 1993 Jan 01; 33(11):48-54, 5-6. PubMed ID: 8145424
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemia.
    Bradford RH, Downton M, Chremos AN, Langendörfer A, Stinnett S, Nash DT, Mantell G, Shear CL.
    Ann Intern Med; 1993 Jun 01; 118(11):850-5. PubMed ID: 8480959
    [Abstract] [Full Text] [Related]

  • 39. [Lovastatin in the treatment of hypercholesterolemia].
    Adamska-Dyniewska H, Chojnowska-Jezierska J, Cybulska B, Grzymisławski M, Hryniewiecki L, Kaliciński A, Kawecka-Jaszcz K, Kleinrok A, Kłos ZJ, Kokot F.
    Pol Arch Med Wewn; 1994 Jul 01; 92(1):54-62. PubMed ID: 7971478
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and tolerability of lovastatin in a six-month study: analysis by gender, age and hypertensive status.
    Kannel WB, D'Agostino RB, Stepanians M, D'Agostino LC.
    Am J Cardiol; 1990 Sep 18; 66(8):1B-10B. PubMed ID: 2206030
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.